-
Product Insights
Inclusion Body Myositis (IBM) – Drugs In Development, 2023
Global Markets Direct’s, ‘Inclusion Body Myositis (IBM) - Drugs In Development, 2023’, provides an overview of the Inclusion Body Myositis (IBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Inclusion Body Myositis (IBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Hereditary Inclusion Body Myopathy (h-IBM) – Drugs In Development, 2023
Global Markets Direct’s, ‘Hereditary Inclusion Body Myopathy (h-IBM) - Drugs In Development, 2023’, provides an overview of the Hereditary Inclusion Body Myopathy (h-IBM) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hereditary Inclusion Body Myopathy (h-IBM), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
IBM Gunbarrel facility Solar PV Park
IBM Gunbarrel facility Solar PV Park is a solar PV project located in Minnesota, United States. The project is owned and developed by NextEra Energy Inc. The project came online in 2019. Empower your strategies with our IBM Gunbarrel facility Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ulviprubart in Inclusion Body Myositis (IBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Ulviprubart in Inclusion Body Myositis (IBM) Drug Details: AB-008 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Froniglutide in Inclusion Body Myositis (IBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Froniglutide in Inclusion Body Myositis (IBM) Drug Details: Froniglutide (formerly PB-1023) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABC-008 in Inclusion Body Myositis (IBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ABC-008 in Inclusion Body Myositis (IBM) Drug Details: AB-008 is under development for the treatment...
-
Thematic Analysis
NewBlockchain – Thematic Intelligence
Blockchain Thematic Intelligence Report Overview Blockchain is a type of distributed ledger comprising unchangeable, digitally recorded data in packages called blocks. Each block is ‘chained’ to the next block using a cryptographic signature. The four key characteristics that make blockchain uniquely different from traditional databases are decentralization, cryptography, validation, and immutability. Key Features of Blockchain Technology Buy the Full Report to Know More About the Key Features of Blockchain Technology, Download a Free Report Sample With the hype around blockchain...
-
Thematic Analysis
NewQuantum Computing – Thematic Intelligence
Quantum Computing Thematic Intelligence Report Overview Quantum computers use the properties of quantum physics to store data and perform computations. There are many technologies with the potential to build their foundational quantum bits (qubits). However, it may well be over a decade before companies can deliver the enmeshed systems of high-fidelity qubits needed to usher in the quantum era. The fiendishly difficult engineering problems, excess hype, and pre-revenue phase for many quantum companies mean a protracted quantum winter is in...
-
Analyst Opinions
NewInnovations in Accounts and Cash Management – Trends, Drivers and Opportunities, 2024
This report provides a roundup of innovations within multiple retail banking and wealth management markets, with particular focus on savings accounts and cash management. The report explores the shifts in customer behavior regarding bank branches, spending drivers, financial education, savings, investment platforms, and robo-advisors. Despite a challenging year, there was growth in assets among the emerging and mass affluent, fueling interest in the segments. Specifically, markets in the Association of Southeast Asian Nations (ASEAN) are experiencing strong growth, meaning banks...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Arimoclomol Citrate ER in Niemann-Pick Disease Type C
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Arimoclomol Citrate ER in Niemann-Pick Disease Type C Drug Details: Arimoclomol citrate (BRX-220) was under...